Sponsored by:
Precision Oncology Drug Development in China: Opportunities, Challenges, and Fast Paths Forward
Listen to this article
Sponsored by:
Learn more about how China’s biopharmas are going global by working with dependable and trustworthy companion diagnostics partners like Guardant Health in precision oncology drug development clinical trials.
Keep up with the top pharma business news of the week. On the go.
Sponsored by:
More from China
A framework to end the Iran war is in place but fractured supply chains can’t recover overnight. Data from India suggests solvent prices have generally cooled from April peaks, but API costs stay elevated or even climbed in June for some products.
• By
Already one of the world’s largest pharmaceutical markets, China has tremendous growth potential, but significant policy and market changes are rocking the basis of competition. Multinational biopharma corporations cannot succeed in this new environment unless they fundamentally reinvent their business models to adapt to sweeping change.
Pipelines in bioconjugates continue to develop, from ADCs to XDCs, with radionuclide drug conjugates (RDCs) and antibody-oligonucleotide conjugates (AOCs) leading the expansion.
Interim results from the Phase III REMARK study presented at WCLC showed the Chinese company’s second-generation ALK/ROS1 inhibitor met its primary endpoint as a first-line therapy in ALK-positive advanced NSCLC.
More from Scrip
Sponsored by :
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
Primal Pictures
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
Sponsored by
sponsored by